HomeADVM • NASDAQ
add
Adverum Biotechnologies Inc
Previous close
$4.17
Day range
$4.15 - $4.28
Year range
$1.78 - $6.12
Market cap
94.05M USD
Avg Volume
899.40K
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
In the news
Financials
Income Statement
Revenue
Net income
| (USD) | Sep 2025info | Y/Y change |
|---|---|---|
Revenue | — | — |
Operating expense | 46.94M | 36.66% |
Net income | -47.65M | -47.30% |
Net profit margin | — | — |
Earnings per share | -2.03 | -56.15% |
EBITDA | -47.56M | -41.76% |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Sep 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 26.06M | -82.99% |
Total assets | 72.40M | -69.11% |
Total liabilities | 128.05M | 41.87% |
Total equity | -55.65M | — |
Shares outstanding | 22.08M | — |
Price to book | -1.65 | — |
Return on assets | -142.43% | — |
Return on capital | -228.05% | — |
Cash Flow
Net change in cash
| (USD) | Sep 2025info | Y/Y change |
|---|---|---|
Net income | -47.65M | -47.30% |
Cash from operations | -28.12M | -33.10% |
Cash from investing | 1.86M | 113.92% |
Cash from financing | 9.90M | — |
Net change in cash | -16.36M | 52.54% |
Free cash flow | -11.26M | 25.10% |
About
Adverum Biotechnologies, Inc., formerly known as Avalanche Biotechnologies, is a publicly traded clinical stage gene therapy company located in Redwood City, California. The company is targeting unmet medical needs for serious ocular and rare diseases, including wet age-related macular degeneration. Wikipedia
Founded
Jan 1, 2006
Headquarters
Website
Employees
155
